Tobacco giant Philip Morris International (PMI) has bought a 22.61 percent stake in British asthma inhaler maker Vectura. Following the deal, PMI announced that it plans to continue acquiring Vectura shares on the market at 165p (RUB167) per share. informs CNBC.
PMI is interested in Vectura, as it believes that in the future, the acquisition of the company will allow it to earn more. The cigarette maker is counting on the absorption of Vectura, intending increase their revenues from the sale of goods and services not related to nicotine, up to a billion dollars a year. It is assumed that PMI will gain access to inhaler technologies for the production of alternative smoking systems, however, the production of the asthma drugs Vectura will continue after the takeover.
Read Also
- Elon Musk confirms a new generation of his satellite internet, Starlink 2.0 Jun 1, 2022
- iOS 14: Function for hearing protection annoys users Dec 21, 2020
- Euro 2022: Les Bleues in the semi-finals after their victory against Germany Nov 15, 2022
- Amper acquires all of Rubricall and Soax | News | Market May 31, 2021
- Sonego with Alcaraz, but the rain stops everything. It is also up to Berrettini and Fognini Aug 17, 2021
- How did the Egyptian thunderbolt respond to the terrorist attack of ISIS? Jul 8, 2021
- Tronsmart Studio review: lots of power in 30W Aug 28, 2021